Industrial Purity L-M-Tyrosine Coa Specifications
- High Purity Standards: Specifications typically require HPLC purity exceeding 98.0% for research-grade applications.
- Comprehensive COA: Certificates of Analysis must detail heavy metals, residual solvents, and specific rotation data.
- Bulk Availability: Industrial scales are supported by verified global manufacturers with GMP-compliant facilities.
In the realm of advanced pharmaceutical synthesis and biochemical research, the reliability of raw materials is paramount. L-m-Tyrosine, chemically known as 3-Hydroxyphenylalanine, serves as a critical building block for various bioactive compounds. Unlike its ortho and para isomers, this meta-substituted amino acid exhibits unique reactivity profiles that are essential for developing specific kinase inhibitors and signaling modulators. Ensuring that every batch meets rigorous industrial purity standards is the primary responsibility of a dedicated global manufacturer like NINGBO INNO PHARMCHEM CO.,LTD.
Procurement teams and quality control managers must scrutinize the Certificate of Analysis (COA) to verify consistency. This document is not merely a formality; it is the definitive record of the material's chemical identity and safety profile. When evaluating suppliers, buyers should look for detailed chromatographic data that confirms the absence of regioisomers, such as L-tyrosine or L-o-tyrosine, which can interfere with downstream reactions.
Understanding HPLC Purity Standards Above 98 Percent
The cornerstone of quality assurance for any pharmaceutical intermediate is the assay value determined by High-Performance Liquid Chromatography (HPLC). For research and development purposes, a minimum purity of 98.0% is generally accepted, though specialized applications may demand 99.0% or higher. The synthesis route employed significantly influences the impurity profile. Enzymatic resolution or chiral catalysis often yields higher enantiomeric excess compared to traditional chemical synthesis.
Impurities in Metatyrosine batches often include unreacted starting materials, halogenated byproducts from substitution steps, or oxidation products. A robust COA will list these potential impurities with their respective limits. For instance, heavy metals such as lead, arsenic, and mercury must be controlled to ppm levels according to ICH Q3D guidelines. Furthermore, residual solvents from the crystallization process, such as methanol or acetone, must be quantified using Gas Chromatography (GC) to ensure safety for laboratory personnel.
Verifying Batch Consistency With Certificate of Analysis
A comprehensive COA provides the technical data necessary to validate the material before it enters the production line. Key parameters include specific rotation, which confirms the stereochemistry of the L-isomer, and loss on drying, which indicates moisture content. High moisture levels can affect weighing accuracy and stability during storage. Below is a typical specification table for high-purity grades available from top-tier suppliers.
| Test Item | Specification Standard | Typical Result |
|---|---|---|
| Appearance | White to Off-White Crystalline Powder | White Crystalline Powder |
| Identification (IR) | Consistent with Reference Standard | Complies |
| Assay (HPLC) | ≥ 98.0% | 98.5% |
| Specific Rotation [α]D | -10.0° to -12.0° (c=1, 1M HCl) | -11.2° |
| Loss on Drying | ≤ 0.5% | 0.3% |
| Residue on Ignition | ≤ 0.1% | 0.05% |
| Heavy Metals | ≤ 10 ppm | < 5 ppm |
Safety data is another critical component of the documentation. While this compound is primarily for research, handling precautions are necessary. Standard safety statements often advise avoiding breathing dust or vapors and wearing appropriate protective equipment. Hazard statements may indicate potential irritation to skin, eyes, or the respiratory system, necessitating proper ventilation in industrial settings.
Factory Standard Compliance for Pharmaceutical Intermediates
Compliance extends beyond the chemical specification to the manufacturing environment. Facilities producing (S)-2-Amino-3-(3-hydroxyphenyl)propanoic acid should adhere to strict quality management systems. This includes controlled access, environmental monitoring, and validated cleaning procedures to prevent cross-contamination. For buyers sourcing materials for sensitive assays involving pathways such as MAPK/ERK or PI3K/Akt/mTOR, even trace contaminants can skew results.
Reliable suppliers maintain batch records that allow for full traceability from raw material intake to final packaging. This transparency is vital for audit purposes and regulatory filings. When scaling up from milligram to kilogram quantities, maintaining the same industrial purity profile is a challenge that only experienced producers can meet consistently. NINGBO INNO PHARMCHEM CO.,LTD. ensures that bulk orders match the quality of laboratory samples through rigorous process validation.
Commercial Viability and Bulk Procurement
The bulk price of amino acid derivatives fluctuates based on raw material availability and synthesis complexity. However, securing a long-term contract with a verified manufacturer stabilizes costs and ensures supply chain continuity. Buyers should request samples for internal validation before committing to large volumes. This step confirms that the material performs as expected in specific applications, whether it be enzyme kinetics studies or chemical conjugation processes.
When sourcing high-purity L-m-Tyrosine, buyers should prioritize suppliers who provide full technical support and custom synthesis capabilities. The ability to modify particle size or packaging specifications adds significant value for industrial clients. Additionally, understanding the logistics of international shipping, including proper HS code classification and stability during transit, is essential for seamless procurement.
In conclusion, the selection of L-m-Tyrosine for research or development hinges on the integrity of the COA and the reputation of the producer. By focusing on verified specifications, safety compliance, and manufacturing transparency, organizations can mitigate risk and accelerate their project timelines. Partnering with a dedicated entity ensures access to materials that meet the demanding standards of modern chemical biology.